Biomerica BMRA 深 沪
等待开盘 10-06 09:30:00 美东时间
2.05
-0.110
-5.09%
华盛通- 最 高2.84
- 今 开2.12
- 成交量 3.37万股
- 最 低 1.601
- 昨 收 2.16
- 总市值 2.63万
- 52周最高 3.2133
- 市盈率 静 --
- 换手率 262.05%
- 52周最低 1.45
- 委 比 4.43%
- 总股本 1.29万
- 历史最高 187.12
- 量 比 7.59
- 振 幅 57.36%
- 历史最低 1.45
- 每 手 1
- 风险率 0.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Biomerica Files $250M Shelf Registration Statement For Mixed Securities Offering
BIOMERICA, INC. $250,000,000 Common StockPreferred StockDebt SecuritiesWarrants We may offer and sell the securities identified above from time to time in one or more offerings, in amounts, at prices and on terms
09-26 03:01
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair
Biomerica appoints Eric B. Chin to its Board of Directors, who brings over 20 years of financial experience in healthcare. As CFO of Akido Labs, he raised $60 million and will strengthen Biomerica's corporate governance and financial oversight during its growth phase.
2025-06-06 13:30
Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System
Biomerica's inFoods® IBS product reduces GI pain and bloating by 48.5% and 49.8% respectively, utilizing personalized dietary adjustments and a real-time feedback system to enhance symptom management.
2025-05-22 12:19
艾里德克斯盘中异动 下午盘股价大涨6.15%
北京时间2024年12月03日03时11分，艾里德克斯（IRIX.us）股票出现异动，股价急速上涨6.15%。截至发稿，该股报1.90美元/股，成交量3.6983万股，换手率0.22%，振幅3.91%。 最近的财报数据显示，该股实现营业收入11.58百万美元，净利润-1.93百万美元，每股收益-0.12美元，毛利4.19百万美元，市盈率-2.73倍。 机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。 艾里德克斯股票所在的医疗器械行业中，整体跌幅为0.71%。其相关个股中，Spectral Ai Inc C/Wts (To Pur Com)、Novocure Limited、Spe...
2024-12-03 03:11
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) rose sharply in today's pre-ma...
2024-09-09 18:08
Biomerica Q4 EPS $(0.09) Up From $(0.10) YoY, Sales $1.12M Up From $1.11M YoY
Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.09) per share. This is a 10 percent increase over losses of $(0.10) per share from the same period last year. The company reported $1.12 million in sales this quarter. This is a 0.90 percent increase over sales of $1.11 million the same period...
2024-08-29 21:06
